AzTrials
AzTrials

Heart DiseasesNCT00155285

Evaluating the Infant Complex Congenital Heart Disease by Multidetector Computed Tomography

A study testing computed tomography in people with Heart Diseases, run by National Taiwan University Hospital at 2 sites in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To test the ability of multi-detector spiral CT in evalting the infant complex congenital heart disease. Read more about this study

Who is it for?
Ages 1 day to 20 years
Conditions the study is for
Heart Diseases
What is being tested?
computed tomography
Type of treatment
Surgery or procedure
How many people
200 participants
Where
2 sitesTaiwan
Study dates
Jan 2000to Dec 2006
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 20 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • complex congenital heart disease

Who cannot join

  • -

Trial locations and contacts

2 sites in 1 country.

Shyh-Jye Chen, MD, PhD contact

886-2-23565586

james@ntumc.org

Taiwan2 sites, 2 recruiting
  • Dept. Medical Imaging, NTUH

    Taipei, 100

    Shyh-Jye Chen, MD, PhD, +886-23565586, james@ntumc,org

    Shyh-Jye Chen, MD, PhD

    Recruiting
  • National Taiwan University Hospital

    Taipei, 100

    Shyh-Jye Chen, MD, PhD, +886-2-23565586, james@ntumc.org

    Recruiting

Other trials in Taiwan

About this study

Official title: Integrated Evaluating the Infant Complex Congenital Heart Disease by Multidetector(16)Spiral Computed Tomography

To test the ability of multi-detector spiral CT in evalting the infant complex congenital heart disease.

Read the detailed description

To test the ability of multi-detector spiral CT in evalting the infant complex congenital heart disease.

Conditions
Heart Diseases
Keywords
heart diseases, congenital
Medical subject headings
Heart Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Diagnostic accuracy

Secondary outcomes (1)
  1. sensitivity, specificity

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Sep 2005 (estimated)
  2. Study startJan 2000
  3. Study completionDec 2006

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Single group
Masking
Single blind
Enrolment
200 participants
IDs, dates and publications
ClinicalTrials.gov ID
NCT00155285
Sponsor's protocol ID
9361700485
Status last verified
Apr 2003
First submitted
8 Sep 2005
Last updated
20 Oct 2005
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing computed tomography in people with Heart Diseases, run by National Taiwan University Hospital at 2 sites in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Oct 2005. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Shyh-Jye Chen, MD, PhD (886-2-23565586, james@ntumc.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Diagnostic accuracy. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Oct 2005; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in